FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094607 [Registered on: 11/09/2025] Trial Registered Prospectively
Last Modified On: 10/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   A study of different homoeopathic potencies in the management of uterine fibroids in adult females 
Scientific Title of Study   Comparative study on the efficacy of Centesimal potency VS. Fifty Millesimal potency in the management of Uterine Fibroids in women of reproductive-age (15 to 50 years) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sanhita Vasdev 
Designation  PG student  
Affiliation  Dr D Y Patil Homoeopathic Medical College And Research Centre Pune 
Address  PG student department of Organon of Medicine and Homoeopathic Philosophy Dr D Y Patil Homoeopathic Medical College And Research Centre Sant Tukaram Pimpri Pune

Pune
MAHARASHTRA
412303
India 
Phone  9650983234  
Fax    
Email  sanhitavasdev@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sanhita Vasdev 
Designation  PG 
Affiliation  Dr D Y Patil Homoeopathic Medical College And Research Centre Pune 
Address  Dr D Y Patil Homoeopathic Medical College And Research Centre Sant Tukaram Pimpri Pune


MAHARASHTRA
412303
India 
Phone  9650983234  
Fax    
Email  sanhitavasdev@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sucharita Kulkarni 
Designation  Professor 
Affiliation  Dr D Y Patil Homoeopathic Medical College And Research Centre Pune 
Address  Dr D Y Patil Homoeopathic Medical College And Research Centre Sant Tukaram Pimpri Pune

Pune
MAHARASHTRA
412303
India 
Phone  9422084200  
Fax    
Email  sucharita.kulkarni@dpu.edu.in  
 
Source of Monetary or Material Support  
OPD and IPD complex Department of Organon of Medicine and Homoeopathic Philosophy ground floor Dr D Y Patil Homoeopathic Medical College and Research Centre Sant Tukaram Nagar Pimpri Pune 411018 Maharashtra India  
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanhita Vasdev  Dr D Y Patil Homoeopathic Medical College and Research Centre Sant Tukaram Nagar Pimpri Pune 411018   OPD and IPD complex first floor Department of Organon of Medicine and Homoeopathic philosophy ground floor
Pune
MAHARASHTRA 
09650983234

sanhitavasdev@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr D Y Patil Homoeopathic Medical College Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: D259||Leiomyoma of uterus, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized Homoeopathic Medicine  Individualized Homoeopathic Medicine in Centesimal scale 
Comparator Agent  Individualized Homoeopathic Medicine  Individualized Homoeopathic Medicine in Fifty Millesimal scale  
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  Females of reproductive age group 15 to 50
Diagnosed cases of uterine fibroid
Cases with symptoms related to uterine fibroids
Females with fibroid size less than or equal to 5cm
 
 
ExclusionCriteria 
Details  Females of age below 15 and above 50
Menopausal females
Females with other complications such as PCOS
Females with fibroid size more than 5cm
Females suffering with severe anaemia  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To assess the reduction in size of uterine fibroid   To assess the reduction in size of uterine fibroid in 4 to 6 months  
 
Secondary Outcome  
Outcome  TimePoints 
To assess the symptomatic relief in the patients as per Uterine fibroid symptom & health-related quality of life questionnaire   To assess the symptomatic relief of the patient in 3 to 4 months  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

According to the recent research there has been a surge in the cases of uterine fibroids seen in the past decade The clinical evidence about the utility of Homoeopathy in managing uterine fibroids is limited The previous research either helped to manage the troublesome symptoms or showed decrease in the size of fibroids  As Homoeopathy acts on the whole individual not just on the diseased part This comparative study of two different scale aims to explore the role of Homoeopathy as a holistic approach towards uterine fibroids with the help of  two different potencies that is centesimal scale and fifty millesimal scale given by Dr Hahnemann in 5th and 6th edition of Organon of Medicine respectively to see if there is any difference in the efficacy of the two potencies in the case of uterine fibroid studied in the reproductive age group that is 15 to 50 years

 
Close